Simplex Trading
NVAX icon

Simplex Trading’s Novavax NVAX Stock Holding History

Simplex Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Sell
365,800
-262,700
-42% -$2.38M ﹤0.01% 1509
2025
Q4 		$4.22M Sell
628,500
-119,100
-16% -$898K ﹤0.01% 1415
2025
Q3 		$6.48M Buy
747,600
+120,500
+19% +$938K ﹤0.01% 1247
2025
Q2 		$3.95M Buy
627,100
+286,900
+84% +$1.9M ﹤0.01% 1544
2025
Q1 		$2.18M Sell
340,200
-260,100
-43% -$2.15M ﹤0.01% 1954
2024
Q4 		$4.83M Buy
600,300
+96,900
+19% +$934K ﹤0.01% 1500
2024
Q3 		$6.36M Sell
503,400
-67,300
-12% -$869K ﹤0.01% 1330
2024
Q2 		$7.22M Sell
570,700
-81,700
-13% -$822K ﹤0.01% 1218
2024
Q1 		$3.12M Sell
652,400
-65,600
-9% -$304K ﹤0.01% 1995
2023
Q4 		$3.45M Sell
718,000
-475,200
-40% -$2.91M ﹤0.01% 1876
2023
Q3 		$8.64M Buy
1,193,200
+729,100
+157% +$5.83M 0.01% 996
2023
Q2 		$3.45M Sell
464,100
-451,700
-49% -$3.55M ﹤0.01% 1556
2023
Q1 		$6.35M Buy
915,800
+50,500
+6% +$465K 0.01% 1151
2022
Q4 		$8.89M Buy
865,300
+479,500
+124% +$8.46M 0.01% 905
2022
Q3 		$7.02M Buy
385,800
+106,800
+38% +$4.63M 0.01% 986
2022
Q2 		$14.3M Sell
279,000
-82,100
-23% -$4.25M 0.02% 643
2022
Q1 		$26.6M Buy
361,100
+4,000
+1% +$357K 0.02% 440
2021
Q4 		$51.1M Buy
357,100
+232,200
+186% +$39.9M 0.05% 268
2021
Q3 		$26.9M Buy
124,900
+8,500
+7% +$1.87M 0.03% 374
2021
Q2 		$24.7M Buy
116,400
+114,744
+6,929% +$21M 0.02% 386
2021
Q1 		$30M Sell
1,656
-508
-23% -$101K 0.05% 215
2020
Q4 		$24.1M Buy
2,164
+230
+12% +$24.4K 0.03% 309
2020
Q3 		$21M Buy
1,934
+535
+38% +$65.2K 0.03% 324
2020
Q2 		$11.7M Sell
1,399
-389
-22% -$14.9K 0.02% 464
2020
Q1 		$2.43M Buy
1,788
+119
+7% +$1.01K ﹤0.01% 1132
2019
Q4 		$664K Buy
1,669
+1,074
+181% +$4.66K ﹤0.01% 2467
2019
Q3 		$298K Sell
595
-228
-28% -$1.25K ﹤0.01% 3171
2019
Q2 		$481K Buy
823
+715
+662% +$5.63K ﹤0.01% 2600
2019
Q1 		$119K Buy
108
+75
+227% +$2.37K ﹤0.01% 4162
2018
Q4 		$120K Buy
33
+12
+57% +$465 ﹤0.01% 3668
2018
Q3 		$80K Buy
21
+16
+320% +$451 ﹤0.01% 4677
2018
Q2 		$13K Sell
5
-6
-55% -$203 ﹤0.01% 6174
2018
Q1 		$9K Sell
11
-15
-58% -$603 ﹤0.01% 4142
2017
Q4 		$6K Hold
26
– – ﹤0.01% 4356
2017
Q3 		$5K Buy
26
+6
+30% +$134 ﹤0.01% 4404
2017
Q2 		$7K Buy
20
+5
+33% +$98 ﹤0.01% 4309
2017
Q1 		$2K Sell
15
-16
-52% -$440 ﹤0.01% 5300
2016
Q4 		$7K Sell
31
-20
-39% -$583 ﹤0.01% 4067
2016
Q3 		$18K Sell
51
-8
-14% -$1.03K ﹤0.01% 3078
2016
Q2 		$236K Buy
59
+43
+269% +$4.93K 0.02% 903
2016
Q1 		$9K Sell
16
-34
-68% -$3.65K ﹤0.01% 3580
2015
Q4 		$89K Buy
50
+6
+14% +$923 0.01% 1450
2015
Q3 		$52K Buy
44
+42
+2,100% +$9.42K ﹤0.01% 1965
2015
Q2 		$8K Sell
2
-3
-60% -$527 ﹤0.01% 3264
2015
Q1 		$33K Buy
5
+3
+150% +$487 ﹤0.01% 1880
2014
Q4 		$9K Buy
+2
New +$209 ﹤0.01% 2663

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NVAX Position: Q3 2025 in Review

Simplex Trading sold out of Novavax (NVAX) in Q3 2025, closing a stake of 216,099 shares — an estimated $1.68M sold.

Simplex Trading first reported a position in NVAX in Q1 2015 and held it in 30 quarters. The position peaked at $17.3M in Q4 2021. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Simplex Trading reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 216,099 Novavax shares in Q3 2025, an estimated $1.68M.
  • Simplex Trading first reported a position in Novavax in Q1 2015 and held it in 30 quarters.
  • Simplex Trading's Novavax position peaked at $17.3M in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.